Guardian Wealth Management (Illinois)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
AAMU
AIM
AV
MIF
ZIC
Guardian Wealth Management (Illinois)'s AZN Position: Q2 2026 in Review
Guardian Wealth Management (Illinois) reduced its AstraZeneca (AZN) stake by 13% in Q2 2026, selling an estimated $39.5K and leaving 1,392 shares worth $264K. The position accounts for 0.13% of the portfolio, ranked #59.
Guardian Wealth Management (Illinois) first reported a position in AZN in Q4 2021 and has held it in 19 quarters since. The position peaked at $774K in Q2 2023. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Guardian Wealth Management (Illinois) held 1,392 shares of AstraZeneca worth $264K as of Q2 2026.
- Guardian Wealth Management (Illinois) sold 210 AstraZeneca shares in Q2 2026, an estimated $39.5K.
- AstraZeneca made up 0.13% of Guardian Wealth Management (Illinois)'s portfolio in Q2 2026, its #59 holding.
- Guardian Wealth Management (Illinois) first reported a position in AstraZeneca in Q4 2021 and has held it in 19 quarters since.
- Guardian Wealth Management (Illinois)'s AstraZeneca position peaked at $774K in Q2 2023.
- 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Guardian Wealth Management (Illinois)'s 13F filing for Q2 2026, filed 13 Jul 2026.